All filters
Abstracts
Uptake of HIV post-exposure prophylaxis, completion rates and self-reported reasons for non-completion among health care workers at Mbarara Regional Referral Hospital
D. Muzoora Musiime
Reviews in Antiviral Therapy & Infectious Diseases 11, 2021
Presented at:
HIV Prevention Summit 2021
Abstracts
Characterizing Non-Occupational Post Exposure Prophylaxis for HIV in 5 Urban Health Centers of Kampala, Uganda: January 2016 - June 2019
L. Mills
Reviews in Antiviral Therapy & Infectious Diseases 11, 2021
Presented at:
HIV Prevention Summit 2021
Abstracts
Intimate partner violence and gender-based violence among people living with HIV in southern Nigeria
C. Okafor
Reviews in Antiviral Therapy & Infectious Diseases 11, 2021
Presented at:
HIV Prevention Summit 2021
Abstracts
Post-Exposure Prophylaxis, Post-Violence Care and Ongoing HIV Risk: Missed Opportunities for HIV Prevention through Pre-Exposure Prophylaxis and Other Interventions
L. Mills
Reviews in Antiviral Therapy & Infectious Diseases 11, 2021
Presented at:
HIV Prevention Summit 2021
Abstracts
Assessing Knowledge About Pre-exposure Prophylaxis at a Higher Education Institution in The Western Cape, South Africa Using Limited Episodes of The MTV Shuga Series
L. Kweyama
Reviews in Antiviral Therapy & Infectious Diseases 11, 2021
Presented at:
HIV Prevention Summit 2021
Abstracts
Development and implementation of a pre-exposure prophylaxis (PrEP) curriculum for pediatric residents
E. Boyd
Reviews in Antiviral Therapy & Infectious Diseases 11, 2021
Presented at:
HIV Prevention Summit 2021
Abstracts
Increasing visibility, uptake and retention of Pre-Exposure Prophylaxis (PrEP) users among men who have sex with men (MSM) in Nairobi, Kenya through let’s Get Real Events (LGR).
P. Hagono
Reviews in Antiviral Therapy & Infectious Diseases 11, 2021
Presented at:
HIV Prevention Summit 2021
Abstracts
Understanding barriers to HIV Pre-Exposure Prophylaxis scale up in Lusaka urban.
M. Kabongo
Reviews in Antiviral Therapy & Infectious Diseases 11, 2021
Presented at:
HIV Prevention Summit 2021
Abstracts
Burden of HIV infection among the elderly in urban Ethiopia
Y. Misganie
Reviews in Antiviral Therapy & Infectious Diseases 11, 2021
Presented at:
HIV Prevention Summit 2021
Abstracts
The Covid-19 pandemic and its effect on the sex market in Mexico City
C. Chivardi
Reviews in Antiviral Therapy & Infectious Diseases 11, 2021
Presented at:
HIV Prevention Summit 2021
Abstracts
Perceptions of the Effectiveness of Health Education Strategies in Reducing Harm from HIV in Libyan Married Women
A. Hamidi
Reviews in Antiviral Therapy & Infectious Diseases 11, 2021
Presented at:
HIV Prevention Summit 2021
E-Posters
Development and Implementation of a Pre-exposure Prophylaxis (PrEP) Curriculum for Pediatric Residents
E. Boyd
Presented at:
HIV Prevention Summit 2021
E-Posters
The Covid-19 pandemic and its effect on the sex market in Mexico City
C. Chivardi
Presented at:
HIV Prevention Summit 2021
E-Posters
Increasing visibility, uptake and retention of Pre-Exposure Prophylaxis (PrEP) users among men who have sex with men (MSM) in Nairobi, Kenya through let’s Get Real Events (LGR).
P. Hagono
Presented at:
HIV Prevention Summit 2021
E-Posters
Perceptions of the Effectiveness of Health Education Strategies in Reducing Harm from HIV in Libyan Married Women
A. Hamidi
Presented at:
HIV Prevention Summit 2021
E-Posters
Understanding barriers to HIV Pre-Exposure Prophylaxis scale up in Lusaka urban.
M. Kabongo
Presented at:
HIV Prevention Summit 2021
Slidesets
Novel Drug Delivery Systems on the Horizon - Charles Flexner, MD
Presented at:
HIV Prevention Summit 2021
Slidesets
Whatever Happened with PEP - Fiona Cresswell, PhD, MBChB, BSc, DTM&H, PGCert Epi, DipGUM, DFSRH
Presented at:
HIV Prevention Summit 2021
Slidesets
Successful Models of PrEP Implementation - François Venter, MD, FCP, PhD
Presented at:
HIV Prevention Summit 2021
Slidesets
Successes to Access PrEP and PEP End-User Perspective - Gcobisa Madlolo
Presented at:
HIV Prevention Summit 2021
Slidesets
The Prevention Pipeline and Clinical Trial Design for PrEP - Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD
Presented at:
HIV Prevention Summit 2021
Slidesets
Why Don't Prescribers Prescribe - Douglas Krakower, MD
Presented at:
HIV Prevention Summit 2021
Slidesets
Overview of Clinical Data on the Safety and Efficacy of Antiretroviral Drugs for HIV Prevention - Roy M. Gulick, MD, MPH
Presented at:
HIV Prevention Summit 2021
Slidesets
WHO Perspective on HIV Prevention - What Are the Gaps - Rachel Baggaley, MBBS, MSc
Presented at:
HIV Prevention Summit 2021